Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for VTE prevention in advanced cancer
NCT00320255Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2006
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of apixaban in venous thromboembolism (VTE), sponsored by Bristol Myers Squibb. Started Jun 2006; status: completed.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00320255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00320255.